) 3.66 3 .48 3.31 5% 11% Consolidated Revenue1 3,240 2,722 2,942 19% 10% Core EBITDA2,3 369 255 304 45% 21% Combined PET 260 177 192 47% 35% Integrated Oxides and Derivatives 37 13 50 191% (26)% Fibers 72
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q3 31/12/2021 2022 Reviewed Consolidated Q3 31/12/2021 2022 Reviewed Company Q2
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Company Year 31/01/2022 2022 Consolidated Year 31/01/2022 2022 Reviewed Company Q3 31/10/2021
/2022 2022 Reviewed Consolidated Q2 30/06/2022 2022 Reviewed Company Q1 31/03/2022 2022 Reviewed Consolidated Q1 31/03/2022 2021 Company Year 31/12/2021 2021 Consolidated
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q2 30/06/2022 2022 Reviewed Consolidated Q2 30/06/2022 2022 Reviewed Company Q1
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2023 Reviewed Company Q1 31/05/2022 2023 Reviewed Consolidated Q1 31/05/2022 2022 Company Year 28/02